Polyrizon Ltd.
NASDAQ: PLRZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Tomer Izraeli
- Employees
- 2
- Headquarters
- Ra'anana, Israel
- IPO year
- 2024
- Market cap
- $13.4M
- Website
- https://www.polyrizon-biotech.com
Loading PLRZ…
Loading profile data…Frequently asked questions about PLRZ
What does Polyrizon Ltd. (PLRZ) do?
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features s...
Where does PLRZ trade?
Polyrizon Ltd. (PLRZ) trades on the NASDAQ Global Market.
What sector is PLRZ in?
Polyrizon Ltd. (PLRZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Polyrizon Ltd.?
Tomer Izraeli is the chief executive officer of Polyrizon Ltd. (PLRZ).
Where is Polyrizon Ltd. headquartered?
Polyrizon Ltd. is headquartered in Israel.
Does PLRZ pay a dividend?
Polyrizon Ltd. (PLRZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PLRZ go public?
Polyrizon Ltd. (PLRZ) completed its initial public offering in 2024.